Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted
Thesis Summary

Semtech entered the second half of FY2027 with substantial operating momentum: Q2 net sales reached a record $341.9 million, adjusted gross margin was 54.5%, and adjusted operating margin was 24.4%. Management's Q3 outlook calls for another sharp revenue increase and further margin expansion, supported by accelerating bookings, record backlog, AI-data-center products and LoRa.

Sign in / Sign up to read more
This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.
Street view · analyst 12-month targets12 analysts · as of 18 Aug 2026
Low · most bearish analyst$175.00
Mean target$205.25
High · most bullish analyst$230.00
Street targets sit above today's price; our intrinsic value sits below it. Different horizons, different questions.
Our research · scenarios, merits, risks, and invalidation triggersResearch as of 2 Sep 2026
Scenarios · 12-month scenario targetsAnchored at research date
Bear CaseDownside scenario
$175.0020%

Revenue or margins fall below the Q3 guidance ranges as AI-related demand concentration, semiconductor cyclicality, customer concentration, supply constraints, trade restrictions or divestiture execution issues interrupt backlog conversion.

Base CaseCentral scenario
$205.2555%
Matches the consensus mean

Semtech performs broadly within its Q3 revenue and margin guidance while progressing the cellular-module divestiture. Growth remains strong but moderates after the initial product ramps.

Bull CaseUpside scenario
$230.0025%

Bookings and backlog convert at or above the Q3 outlook, high-margin AI-data-center and LoRa products drive mix improvement, and portfolio optimization produces a more focused and predictable earnings profile.

Scenarios are anchored to street consensus at the research date, with our probabilities and rationale.

Key Investment Merits
  • Q2 FY2027 net sales increased 33% year over year to a record $341.9 million, while adjusted operating margin expanded to 24.4%.
  • The Q3 FY2027 outlook calls for $410.0 million of net sales, plus or minus $5.0 million, and a 31.0% adjusted operating margin, plus or minus 60 basis points.
  • Management reported accelerating bookings and record backlog, while the cellular-module business was classified as held for sale and new LoRa products entered production.
Sign in / Sign up to read more
Key Investment Risks
  • Demand is increasingly exposed to AI-related semiconductors and remains subject to semiconductor cyclicality, declining average selling prices and concentration among a limited number of customers.
  • Semtech depends on a limited number of suppliers and subcontractors and is exposed to capacity constraints, export restrictions, tariffs and adverse economic conditions in China.
  • The pending cellular-module divestiture introduces execution risk, while indebtedness and related covenants may constrain strategic flexibility.
Sign in / Sign up to read more

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Explore this dossier

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.